Eli Lilly & Co. reported record profits...

Eli Lilly & Co. reported record profits and sales for its fourth quarter and full year, attributing the gains to improved results in all its basic businesses. In the fourth quarter, profit for the Indianapolis-based pharmaceuticals company rose 27% to $175.7 million, paving the way for an 18% rise in full-year earnings to a record $761 million, its 28th consecutive yearly increase. Revenue in the quarter rose 15% to $1.04 billion. For the year, it grew 12% to $4.07 billion.